Exact Mass: 343.3086

Exact Mass Matches: 343.3086

Found 107 metabolites which its exact mass value is equals to given mass value 343.3086, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

8-Methylundecanoylcarnitine

3-[(8-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


8-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 8-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 8-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Methylundecanoylcarnitine

3-[(7-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


7-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 7-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Methylundecanoylcarnitine

3-[(6-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


6-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 6-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Methylundecanoylcarnitine

3-[(4-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


4-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methylundecanoylcarnitine

3-[(5-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


5-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Methylundecanoylcarnitine

3-[(10-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


10-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 10-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 10-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Methylundecanoylcarnitine

3-[(9-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


9-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 9-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 9-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylundecanoylcarnitine

3-[(3-methylundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


3-Methylundecanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Palmitoyl Serine

2-hexadecanamido-3-hydroxypropanoic acid

C19H37NO4 (343.2722)


N-palmitoyl serine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Serine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Serine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Serine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Hexadecanoyl-serine

2-METHOXY-5-METHYL-N,N-BIS(1-METHYLETHYL)-GAMMA-PHENYLBENZENEPROPANAMINEFUMARATE

C19H37NO4 (343.2722)


   

N-Acetylsphinganine

N-(1,3-Dihydroxyoctadecan-2-yl)ethanimidate

C20H41NO3 (343.3086)


   

Sitamaquine

8-(6-Diethylaminohexylamino)-6-methoxy-4-methylquinoline dihydrochloride

C21H33N3O (343.2623)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

(+)-17-Oxocycloprotobuxine

(+)-17-Oxocycloprotobuxine

C23H37NO (343.2875)


   
   

Sitamaquine

Sitamaquine

C21H33N3O (343.2623)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

O-dodecanoylcarnitine

O-dodecanoylcarnitine

C19H37NO4 (343.2722)


An O-acylcarnitine having dodecanoyl as the acyl substituent.

   

(+)-3-deoxybuxandonine

(+)-3-deoxybuxandonine

C24H41N (343.3239)


   

3beta-Dimethylamino-20-oxo-pregnen-5|3beta-Dimethylamino-5-pregnen-20-on|Dimethylholaphyllamin|Methyl-holaphyllin|Methylholaphyllin

3beta-Dimethylamino-20-oxo-pregnen-5|3beta-Dimethylamino-5-pregnen-20-on|Dimethylholaphyllamin|Methyl-holaphyllin|Methylholaphyllin

C23H37NO (343.2875)


   

(20R)-3beta-Dimethylamino-18,20-oxido-pregnen-5|(20R)-N,N-Dimethyl-3beta-amino-18,20-oxido-Delta5-pregnen|3beta-Dimethylamino-18,20beta-oxido-pregn-5-en

(20R)-3beta-Dimethylamino-18,20-oxido-pregnen-5|(20R)-N,N-Dimethyl-3beta-amino-18,20-oxido-Delta5-pregnen|3beta-Dimethylamino-18,20beta-oxido-pregn-5-en

C23H37NO (343.2875)


   

Dimethylholaphyllamine

Dimethylholaphyllamine

C23H37NO (343.2875)


   

(9Z,14Z)-octadeca-9,14-dien-12-ynoic acid piperidine

(9Z,14Z)-octadeca-9,14-dien-12-ynoic acid piperidine

C23H37NO (343.2875)


   

(E)-salignone

(E)-salignone

C23H37NO (343.2875)


   

4-Dihydrofuntumafrine C

4-Dihydrofuntumafrine C

C23H37NO (343.2875)


   

C2 Dihydroceramide

C2 Dihydroceramide

C20H41NO3 (343.3086)


   

(2E,9Z)-octadeca-2,9-dien-12-ynoic acid piperidine

(2E,9Z)-octadeca-2,9-dien-12-ynoic acid piperidine

C23H37NO (343.2875)


   

(3alpha,5alpha)-3-Aminopregn-16-en-20-one

(3alpha,5alpha)-3-Aminopregn-16-en-20-one

C23H37NO (343.2875)


   

(20S)-20-(methylamino)-3beta-methoxypregn-5,16-diene|salignamine

(20S)-20-(methylamino)-3beta-methoxypregn-5,16-diene|salignamine

C23H37NO (343.2875)


   

Arachidonoyl Cyclopropylamide

N-cyclopropyl-5Z,8Z,11Z,14Z-eicosatetraenamide

C23H37NO (343.2875)


   

Lauroylcarnitine

(3R)-3-(dodecanoyloxy)-4-(trimethylazaniumyl)butanoate

C19H37NO4 (343.2722)


Dodecanoylcarnitine is present in fatty acid oxidation disorders such as long-chain acyl CoA dehydrogenase deficiency, carnitine palmitoyltransferase I/II deficiency, and is also associated with celiac disease. Dodecanoylcarnitine is present in fatty acid oxidation disorders such as long-chain acyl CoA dehydrogenase deficiency, carnitine palmitoyltransferase I/II deficiency, and is also associated with celiac disease.

   
   

C15DEA

C15DEA

C20H41NO3 (343.3086)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); May be an alkyl homologue; Digitised from figure: approximate intensities

   

Lauramidopropylbetaine

Lauramidopropylbetaine

[C19H39N2O3]+ (343.2961)


CONFIDENCE standard compound; INTERNAL_ID 2849

   

Putative (3-hydroxyheptadecanoyl)glycine

Putative (3-hydroxyheptadecanoyl)glycine

C19H37NO4 (343.2722)


   

Lauramidopropyl betaine

Lauramidopropyl betaine

[C19H39N2O3]+ (343.2961)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 15

   

Lauroyl-carnitine; AIF; CE0; CorrDec

Lauroyl-carnitine; AIF; CE0; CorrDec

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; AIF; CE10; CorrDec

Lauroyl-carnitine; AIF; CE10; CorrDec

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; AIF; CE30; CorrDec

Lauroyl-carnitine; AIF; CE30; CorrDec

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; AIF; CE0; MS2Dec

Lauroyl-carnitine; AIF; CE0; MS2Dec

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; AIF; CE10; MS2Dec

Lauroyl-carnitine; AIF; CE10; MS2Dec

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; AIF; CE30; MS2Dec

Lauroyl-carnitine; AIF; CE30; MS2Dec

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; LC-tDDA; CE10

Lauroyl-carnitine; LC-tDDA; CE10

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; LC-tDDA; CE40

Lauroyl-carnitine; LC-tDDA; CE40

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; LC-tDDA; CE20

Lauroyl-carnitine; LC-tDDA; CE20

C19H37NO4 (343.2722)


   

Lauroyl-carnitine; LC-tDDA; CE30

Lauroyl-carnitine; LC-tDDA; CE30

C19H37NO4 (343.2722)


   

L-Octanoylcarnitine n-butyl ester

L-Octanoylcarnitine n-butyl ester

C19H37NO4 (343.2722)


   

Dihydroceramide C2

Dihydroceramide C2

C20H41NO3 (343.3086)


   

N-palmitoyl serine

N-hexadecanoyl-serine

C19H37NO4 (343.2722)


   

Behenic acid(d3)

Docosanoic acid(d3)

C22H41D3O2 (343.3529)


   

CAR 12:0

3-(dodecanoyloxy)-4-(trimethylammonio)butanoate;O-lauroylcarnitine;dodecanoylcarnitine;lauroylcarnitine

C19H37NO4 (343.2722)


   

NA 19:1;O3

2-METHOXY-5-METHYL-N,N-BIS(1-METHYLETHYL)-GAMMA-PHENYLBENZENEPROPANAMINEFUMARATE

C19H37NO4 (343.2722)


   

N-(15-methyl-3-hydroxy-hexadecanoyl)-glycine

N-(15-methyl-3-hydroxy-hexadecanoyl)-glycine

C19H37NO4 (343.2722)


   

SPB 21:0;O2

iso (19-methyl-d20:0) sphinganine

C21H45NO2 (343.345)


   

Terbutaline sulfate

Terbutaline sulfate

C12H19NO3.1/2H2O4S (343.2604)


Terbutaline sulfate is an orally active β2-adrenergic receptor agonist and an active metabolite of bambuterol[1]. Terbutaline sulfate can be used in asthma symptom research[2].

   

cedefingol

cedefingol

C20H41NO3 (343.3086)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor

   

N,N-Bis(2-hydroxyethyl)hexadecanamide

N,N-bis(2-hydroxyethyl)hexadecan-1-amide

C20H41NO3 (343.3086)


   

Octadecanamide,12-hydroxy-N-(2-hydroxyethyl)-

Octadecanamide,12-hydroxy-N-(2-hydroxyethyl)-

C20H41NO3 (343.3086)


   

(R,R)-N-BENZYL-3,4-TRANS-DIMESOLATEPYRROLIDINE

(R,R)-N-BENZYL-3,4-TRANS-DIMESOLATEPYRROLIDINE

C19H37NO4 (343.2722)


   

Ethanolamine oleate

monoethanolamine oleate

C20H41NO3 (343.3086)


C - Cardiovascular system > C05 - Vasoprotectives > C05B - Antivaricose therapy > C05BB - Sclerosing agents for local injection D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions C78275 - Agent Affecting Blood or Body Fluid D002317 - Cardiovascular Agents

   

N-Acetylsphinganine

N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]acetamide

C20H41NO3 (343.3086)


A dihydroceramide in which the ceramide acyl group is specified as acetyl.

   

3-(Dodecanoylamino)propyl(carboxymethyl)dimethylammonium

3-(Dodecanoylamino)propyl(carboxymethyl)dimethylammonium

C19H39N2O3+ (343.2961)


   

1,2-Dioctanoyl-1-amino-2,3-propanediol

1,2-Dioctanoyl-1-amino-2,3-propanediol

C19H37NO4 (343.2722)


   

8-Methylundecanoylcarnitine

8-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

7-Methylundecanoylcarnitine

7-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

6-Methylundecanoylcarnitine

6-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

4-Methylundecanoylcarnitine

4-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

5-Methylundecanoylcarnitine

5-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

9-Methylundecanoylcarnitine

9-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

3-Methylundecanoylcarnitine

3-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

10-Methylundecanoylcarnitine

10-Methylundecanoylcarnitine

C19H37NO4 (343.2722)


   

N-acyl-6-hydroxysphingosine

N-acyl-6-hydroxysphingosine

C19H37NO4 (343.2722)


   

N-(3-Hydroxyheptadecanoyl)glycine

N-(3-Hydroxyheptadecanoyl)glycine

C19H37NO4 (343.2722)


   

2-Aminohenicosane-1,3-diol

2-Aminohenicosane-1,3-diol

C21H45NO2 (343.345)


   

N-(1,3-dihydroxyhexadecan-2-yl)butanamide

N-(1,3-dihydroxyhexadecan-2-yl)butanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyoctan-2-yl)dodecanamide

N-(1,3-dihydroxyoctan-2-yl)dodecanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxypentadecan-2-yl)pentanamide

N-(1,3-dihydroxypentadecan-2-yl)pentanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyundecan-2-yl)nonanamide

N-(1,3-dihydroxyundecan-2-yl)nonanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyheptadecan-2-yl)propanamide

N-(1,3-dihydroxyheptadecan-2-yl)propanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxynonan-2-yl)undecanamide

N-(1,3-dihydroxynonan-2-yl)undecanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxytridecan-2-yl)heptanamide

N-(1,3-dihydroxytridecan-2-yl)heptanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxytetradecan-2-yl)hexanamide

N-(1,3-dihydroxytetradecan-2-yl)hexanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxydodecan-2-yl)octanamide

N-(1,3-dihydroxydodecan-2-yl)octanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxydecan-2-yl)decanamide

N-(1,3-dihydroxydecan-2-yl)decanamide

C20H41NO3 (343.3086)


   

O-Lauroyl-L-carnitine

O-Lauroyl-L-carnitine

C19H37NO4 (343.2722)


An O-acyl-L-carnitine in which the acyl group is specified as lauroyl (dodecanoyl).

   

N-hexadecanoyl-serine

2-METHOXY-5-METHYL-N,N-BIS(1-METHYLETHYL)-GAMMA-PHENYLBENZENEPROPANAMINEFUMARATE

C19H37NO4 (343.2722)


   

Sphingosine (t20:1)

SPH(t20:1)

C20H41NO3 (343.3086)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

N-palmitoylserine

(2S)-2-(hexadecanoylamino)-3-hydroxypropanoic acid

C19H37NO4 (343.2722)


-

   

[(1s)-1-[(1s,3r,8r,11r,12s,15s,16r)-12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]dimethylamine

[(1s)-1-[(1s,3r,8r,11r,12s,15s,16r)-12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]dimethylamine

C24H41N (343.3239)


   

1-{3-[9-amino-10-(prop-2-en-1-yl)-1-azatricyclo[5.3.1.1²,⁶]dodecan-12-yl]-5,6-dihydro-4h-pyridin-1-yl}ethanone

1-{3-[9-amino-10-(prop-2-en-1-yl)-1-azatricyclo[5.3.1.1²,⁶]dodecan-12-yl]-5,6-dihydro-4h-pyridin-1-yl}ethanone

C21H33N3O (343.2623)


   

1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

C23H37NO (343.2875)


   

1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

C23H37NO (343.2875)


   

(1e,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

(1e,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

C23H37NO (343.2875)


   

7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

C23H37NO (343.2875)


   

(+/-)-lauroylcarnitine

(+/-)-lauroylcarnitine

C19H37NO4 (343.2722)


   

(1-{7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)(methyl)amine

(1-{7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)(methyl)amine

C23H37NO (343.2875)


   

(1-{12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}ethyl)dimethylamine

(1-{12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}ethyl)dimethylamine

C24H41N (343.3239)


   

1-[(1r,3as,3bs,7s,9ar,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1r,3as,3bs,7s,9ar,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C23H37NO (343.2875)


   

(1s,3r,6s,8r,11s,12s,16s)-7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

(1s,3r,6s,8r,11s,12s,16s)-7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

C23H37NO (343.2875)


   

[(1s)-1-[(3as,3br,7s,9ar,9bs,11as)-7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl](methyl)amine

[(1s)-1-[(3as,3br,7s,9ar,9bs,11as)-7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl](methyl)amine

C23H37NO (343.2875)


   

n-[(2s,3r)-1,3-dihydroxyoctadecan-2-yl]ethanimidic acid

n-[(2s,3r)-1,3-dihydroxyoctadecan-2-yl]ethanimidic acid

C20H41NO3 (343.3086)


   

n-(1,3-dihydroxyoctadecan-2-yl)ethanimidic acid

n-(1,3-dihydroxyoctadecan-2-yl)ethanimidic acid

C20H41NO3 (343.3086)


   

1-[7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C23H37NO (343.2875)


   

(2e,9z)-1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

(2e,9z)-1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

C23H37NO (343.2875)


   

(9z,14z)-1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

(9z,14z)-1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

C23H37NO (343.2875)


   

(2s,6s,9as)-6-{[(7s,8as)-1,7-dimethyl-3,4,6,7,8,8a-hexahydro-2h-quinolin-5-yl]methyl}-2,4-dimethyl-1,2,3,6,7,8,9,9a-octahydro-5λ⁵-quinolizin-5-ylium

(2s,6s,9as)-6-{[(7s,8as)-1,7-dimethyl-3,4,6,7,8,8a-hexahydro-2h-quinolin-5-yl]methyl}-2,4-dimethyl-1,2,3,6,7,8,9,9a-octahydro-5λ⁵-quinolizin-5-ylium

[C23H39N2]+ (343.3113)


   

(1z,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

(1z,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

C23H37NO (343.2875)